Genshin Impact has officially revealed the details of all 4-star characters and weapons that will be featured during Phase 1 ...

Maharashtra is set to begin local body elections on December 2, covering 264 municipal councils and nagar panchayats, with ...

Executive Leadership Programme, an intensive mini MBA designed exclusively for the company’s senior executives, in ...

Imagion Biosystems is on track for IND submission this month and a Phase 2 clinical trial in the US early ... Read More The ...

The latest update is out from Shree Minerals Limited ( (AU:CTN) ).

SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains ...

Durin is a new 5-star Pyro character in Genshin Impact who will be released during the first phase of the Luna III update.

Battlefield’s Season 1 Phase 3 update, Winter Offensive, arrives on December 9. But is it enough to keep Battlefield 6 ...

Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 ...

Belite linked tinlarebant to a 35.7% reduction in lesion growth rate versus placebo, achieving the study’s primary endpoint.

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical ...

A mixed-use facility on the Lakewood-Cleveland border that was built to anchor an LGBTQ+ neighborhood announced on Monday ...